Studies inflammation markers around upcoming vascular surgery
Part of Heart & circulation clinical trials.
This study looks at signs of “inflammation” (your body’s immune response) in people who are scheduled for vascular surgery. It may help researchers understand what’s happening in blood vessel disease and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to have vascular (blood vessel) surgery soon
- You can sign an informed consent form to join the study
- You are 18 years old or older
- You do not have trouble understanding the study information
- You are not currently taking part in another drug-related study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial aims to learn more about blood clots, inflammation, and blood vessel problems. It may help researchers better understand these conditions and how they affect people.
This study looks at genes in people who have atherosclerosis (hardening of the arteries). It will check tissue samples taken during surgery to learn more about how the disease works.
This study looks at artery plaque tissue removed during a routine operation (endarterectomy) to better understand diseased vessel changes. You may be able to join if plaque tissue is part of your planned surgery and you can consent.
This study looks at “angiogenic markers,” which are blood measures that may reflect how blood vessels grow, in people with significant narrowing of a brain artery. It aims to better understand these changes and how they relate to cerebrovascular disease.
This study examines how your body naturally resolves inflammation, which is important for heart health and conditions like diabetes. It involves blood draws and tests to understand how inflammation works.
This study looks at blood vessel cells in three groups: healthy adults, patients having major surgery, and critically ill patients with sepsis. It aims to understand how these cells change in different types of inflammation.
Hear when a new Vascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.